Search Results - "Röseler, Eberhard"

Real‐world study: Escalating targeted lipid‐lowering treatment with PCSK9‐inhibitors and lipoprotein apheresis by Spitthöver, Ralf, Röseler, Tilmann, Julius, Ulrich, Heigl, Franz, Schettler, Volker J. J., Kühn, Ralf, Leebmann, Josef, Raabe, Andrea, Knittel, Markus, Schürfeld, Carsten, Moesenthin, Michael, Bernhardt, Wanja M., Röseler, Eberhard, Ketteler, Markus, Heibges, Andreas, Klingel, Reinhard

“…Introduction Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with monoclonal antibodies has complemented the armamentarium of lipid‐lowering…”
Get full text

Safety aspects of lipidapheresis using DALI and MONET – Multicenter observational study by Kozik-Jaromin, Justyna, Röseler, Eberhard, Heigl, Franz, Spitthöver, Ralf, Ringel, Jens, Schmitz, Gerd, Heinzler, Rainer, Abdul-Rahman, Nadim, Leistikow, Frank, Himmelsbach, Frido, Schettler, Volker, Uhlenbusch-Körwer, Ingrid, Ramlow, Wolfgang

“…Lipidapheresis was introduced for intractable hyperlipidemia as a more selective therapy than plasma exchange aiming to enhance efficacy and limit…”
Get full text

Efficacy of lipid reduction with DALI and MONET by Ramlow, Wolfgang, Röseler, Eberhard, Heigl, Franz, Spitthöver, Ralf, Ringel, Jens, Schmitz, Gerd, Heinzler, Rainer, Abdul-Rahman, Nadim, Leistikow, Frank, Himmelsbach, Frido, Schettler, Volker, Pham, Jenny, Kozik-Jaromin, Justyna

“…Lipidapheresis techniques are increasingly used to treat drug-resistant hyperlipidemia but few efficacy studies under routine application are available. In…”
Get full text